Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Diabetes Technol Ther ; 13(7): 731-6, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21504332

ABSTRACT

BACKGROUND: The purpose of this study was to examine future acceptance of an artificial pancreas (AP) and its perceived usefulness, ease of use, and trust in the device. METHODS: A questionnaire, based on the Technology Acceptance Model, was developed to examine future acceptance with its determinants and intention to use the AP. One hundred thirty-two patients with diabetes type 1 treated with insulin pump therapy completed the questionnaire. Using factor analysis and reliability analysis, the number of items was reduced from 34 to 15. RESULTS: The response rate was 66%. The subjects had a mean age of 43 years, and 34% were male. Almost 75% had the intention to use an AP. There were high scores on perceived usefulness (expected improvement of glucose control: 35.6% moderately agreed and 53% strongly agreed), perceived ease of use (expectation that the AP can be easily handled: 33.3% moderately agreed and 53.8% strongly agreed), and trust (administration of correct insulin dose and reliability of glucose measurement: 40.9% and 38.9% moderately agreed, whereas 32.6% and 28.2% strongly agreed, respectively). CONCLUSIONS: A newly developed questionnaire examining the acceptance of an AP indicated that most patients with continuous subcutaneous insulin infusion-treated type 1 diabetes have the intention to use an AP system and have a positive attitude toward perceived usefulness, ease of use, and trust.


Subject(s)
Diabetes Mellitus, Type 1/psychology , Diabetes Mellitus, Type 1/therapy , Pancreas, Artificial/psychology , Patient Acceptance of Health Care/psychology , Adolescent , Adult , Aged , Diabetes Mellitus, Type 1/drug therapy , Factor Analysis, Statistical , Female , Humans , Hyperglycemia/prevention & control , Hypoglycemia/prevention & control , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Insulin/administration & dosage , Insulin/therapeutic use , Insulin Infusion Systems , Male , Middle Aged , Netherlands , Pilot Projects , Surveys and Questionnaires , Young Adult
2.
J Diabetes Sci Technol ; 5(6): 1337-41, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-22226250

ABSTRACT

BACKGROUND: People with type 1 diabetes mellitus (T1DM) are at risk for exercise-induced hypoglycemia. Prevention of such hypoglycemia in a closed-loop setting is a major challenge. Markers for automated detection of physical activity could be heart rate (HR) and body acceleration counts (AC). Correlations between HR, AC, and glucose concentrations before and after moderate intensity exercise were examined in T1DM patients during open- loop control. METHOD: Eleven T1DM subjects treated with an insulin pump performed moderate intensity exercise of 30 min. Glucose profiles, insulin concentrations, HR, and acceleration were measured. RESULTS: Mean (range) glucose decrease during exercise was 1.4 (0 to 3.3) mmol/liter. The mean increase in HR was 45.2 beats per minutes (15 to 106 bpm). Mean increase in AC was 18,000 (3,000 to 25,000). No correlations were seen between the glucose drop and HR or AC. A trend was observed between the increase in HR and increase in AC. CONCLUSION: Moderate intensity exercise resulted in increased HR and body AC while it decreased glucose concentrations but, in this real-time setting, no association could be demonstrated between the glucose decrease and increase in HR or AC.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus, Type 1/complications , Exercise/physiology , Heart Rate/physiology , Hypoglycemia/prevention & control , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/drug therapy , Female , Humans , Hypoglycemic Agents/administration & dosage , Insulin/administration & dosage , Insulin Infusion Systems , Male , Middle Aged
3.
J Diabetes Sci Technol ; 4(5): 1032-40, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20920423

ABSTRACT

BACKGROUND: Glucose is heterogeneously distributed within human skin. In order to develop a glucose measurement method for human skin, both a good quantification of the different compartments of human skin and an understanding of glucose transport processes are essential. This study focused on the composition of human skin. In addition, the extent to which intersubject variability in skin composition alters glucose dynamics in human skin was investigated. METHODS: To quantify the composition of the three layers of human skin-epidermis, dermis, and adipose tissue-cell and blood vessel volumes were calculated from skin biopsies. These results were combined with data from the literature. The composition was applied as input for a previously developed computational model that calculates spatiotemporal glucose dynamics in human skin. The model was used to predict the physiological effects of intersubject variability in skin composition on glucose profiles in human skin. RESULTS: According to the model, the lag time of glucose dynamics in the epidermis was sensitive to variation in the volumes of interstitial fluid, cells, and blood of all layers. Data showed most variation/uncertainty in the volume composition of the adipose tissue. This variability mainly influences the dynamics in the adipose tissue. CONCLUSIONS: This study identified the intersubject variability in human skin composition. The study shows that this variability has significant influence on the glucose dynamics in human skin. In addition, it was determined which volumes are most critical for the quantification and interpretation of measurements in the different layers.


Subject(s)
Biosensing Techniques/instrumentation , Glucose/analysis , Models, Biological , Monitoring, Physiologic/instrumentation , Skin/chemistry , Adipose Tissue/chemistry , Adipose Tissue/metabolism , Adipose Tissue/pathology , Adult , Biological Transport/physiology , Biopsy , Biosensing Techniques/methods , Dermis/chemistry , Dermis/metabolism , Dermis/pathology , Epidermis/chemistry , Epidermis/metabolism , Epidermis/pathology , Female , Glucose/metabolism , Humans , Male , Middle Aged , Monitoring, Physiologic/methods , Skin/metabolism , Skin/pathology
4.
J Diabetes Sci Technol ; 4(3): 596-602, 2010 May 01.
Article in English | MEDLINE | ID: mdl-20513325

ABSTRACT

BACKGROUND: Little is known of patient acceptance of an artificial pancreas (AP). The purpose of this study was to investigate future acceptance of an AP and its determinants. METHODS: Patients with type 1 diabetes treated with insulin pump therapy were interviewed using questions based on the technology acceptance model and completed the diabetes treatment and satisfaction questionnaire (DTSQ). RESULTS: Twenty-two adults with type 1 diabetes participated. Half of the patients were followed in a university hospital, and the others were under treatment in an affiliated teaching hospital. Half of the patients were male. The mean DTSQ score was 29 (range 23-33). The AP was perceived as likely to be useful. Perceived advantages were a stable glucose regulation, less need for self-monitoring of blood glucose, relief of daily concerns, and time saving. Participants were confident in their capability to use the system. Although many participants (58%) had been reluctant to start continuous subcutaneous insulin infusion, the majority (79%) felt they would have no barriers to start using the AP. Trust in the AP was related to the quality of glucose control it would provide. Almost everyone expressed the intention to use the new system when available, even if it would initially not cover 24/24 hours. CONCLUSION: The overall attitude on the AP was positive. Intention to use was dependent on trust in the AP, which was related to the quality of glucose control provided by the AP.


Subject(s)
Diabetes Mellitus, Type 1/therapy , Pancreas, Artificial/psychology , Patient Acceptance of Health Care/psychology , Adult , Female , Humans , Male , Middle Aged , Perception , Surveys and Questionnaires , Young Adult
5.
J Biomed Opt ; 13(3): 034012, 2008.
Article in English | MEDLINE | ID: mdl-18601557

ABSTRACT

The level of exhaled carbon monoxide (eCO) is considered a marker of oxidative stress in diabetes. Previous findings indicated that eCO levels correlated with blood glucose level. The aim of this work was to apply and compare two independent analyzing methods for eCO after oral glucose administration. Glycemia, eCO, and exhaled hydrogen were measured before and after oral administration of glucose. Six healthy nonsmoking volunteers participated. For eCO analysis, we used two methods: a commercially available electrochemical sensor, and a high-precision laser spectrometer developed in our laboratory. The precision of laser-spectroscopic eCO measurements was two orders of magnitude better than the precision of the electrochemical eCO measurement. eCO levels measured by laser spectrometry after glucose administration showed a decrease of 4.1%+/-1.5% compared to the baseline (p<0.05). Changes in the eCO measured by the electrochemical sensor were not significant (p=0.08). Exhaled hydrogen levels increased by 40% within the first 10 min after glucose administration (p<0.05). The previous finding that the glycemia increase after glucose administration was associated with a significant increase in eCO concentrations was not confirmed. We propose that previous eCO measurements with electrochemical sensors may have been affected by cross sensitivity to hydrogen.


Subject(s)
Blood Glucose/analysis , Breath Tests/methods , Carbon Dioxide/analysis , Electrochemistry/methods , Exhalation/physiology , Lasers , Spectrum Analysis/methods , Adult , Female , Humans , Male , Reproducibility of Results , Sensitivity and Specificity , Statistics as Topic
6.
Isotopes Environ Health Stud ; 41(4): 303-11, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16543186

ABSTRACT

We present a ring-down absorption spectrometer based on a continuous-wave CO laser in the mid-infrared spectral region near lambda = 5 microm. Using a linear ring-down cavity (length: 0.5 m) with high reflective mirrors (R = 99.988 %), we observed a noise-equivalent absorption coefficient of 3 x 10(-10) cm(-1)Hz(-1/2). This corresponds to a noise-equivalent concentration of 800 parts per trillion (ppt) for (14)NO and 40 ppt for (15)NO in 1 s averaging time. We achieve a time resolution of 1 s which allows time resolved simultaneous detection of the two N isotopes. The delta(15)N value was obtained with a precision of +/-1.2 per thousand in a sample with a NO fraction of 11 ppm. The simultaneous detection enables the use of (15)NO as a tracer molecule for endogenous biomedical processes.


Subject(s)
Nitric Oxide/analysis , Nitrogen Isotopes/analysis , Spectrophotometry, Infrared/methods , Lasers , Nitric Oxide/chemistry , Spectrophotometry, Infrared/instrumentation
7.
Opt Lett ; 29(8): 797-9, 2004 Apr 15.
Article in English | MEDLINE | ID: mdl-15119381

ABSTRACT

Spectroscopic detection of ethane in the 3-microm wavelength region was performed by means of a cw optical parametric oscillator and cavity leak-out. We achieved a minimum detectable absorption coefficient of 1.6 x 10(-10) cm 1/square root of Hz, corresponding to an ethane detection limit of 6 parts per trillion/square root of Hz. For 3-min integration time the detection limit was 0.5 parts per trillion. The levels are to our knowledge the best demonstrated so far. These frequency-tuning capabilities facilitated multigas analysis with simultaneous monitoring of ethane, methane, and water vapor in human breath.

8.
J Appl Physiol (1985) ; 95(6): 2583-90, 2003 Dec.
Article in English | MEDLINE | ID: mdl-12897034

ABSTRACT

A method is described for rapidly measuring the ethane concentration in exhaled human breath. Ethane is considered a volatile marker for lipid peroxidation. The breath samples are analyzed in real time during single exhalations by means of infrared cavity leak-out spectroscopy. This is an ultrasensitive laser-based method for the analysis of trace gases on the sub-parts per billion level. We demonstrate that this technique is capable of online quantifying of ethane traces in exhaled human breath down to 500 parts per trillion with a time resolution of better than 800 ms. This study includes what we believe to be the first measured expirograms for trace fractions of ethane. The expirograms were recorded after a controlled inhalation exposure to 1 part per million of ethane. The normalized slope of the alveolar plateau was determined, which shows a linear increase over the first breathing cycles and ends in a mean value between 0.21 and 0.39 liter-1. The washout process was observed for a time period of 30 min and was modelled by a threefold exponential decay function, with decay times ranging from 12 to 24, 341 to 481, and 370 to 1770 s. Our analyzer provides a promising noninvasive tool for online monitoring of the oxidative stress status.


Subject(s)
Breath Tests/methods , Ethane/metabolism , Adult , Algorithms , Breath Tests/instrumentation , Data Interpretation, Statistical , Humans , Lasers , Lipid Peroxidation/physiology , Male , Oxidative Stress/physiology , Pulmonary Alveoli/metabolism , Spectrophotometry, Infrared
SELECTION OF CITATIONS
SEARCH DETAIL
...